The forecast for the import of Phenazone (Antipyrin) to Germany from 2024 to 2028 shows a gradual decline from $5.1936 million in 2024 to $4.9925 million in 2028. This represents a consistent yearly decrease of approximately 1% in value. The data suggests a diminishing demand or a shift in sourcing strategy, contrasting with actual figures prior to 2024.

Future trends to watch for include:

Potential regulatory impacts on pharmaceutical imports.
Fluctuations in global raw material prices.
Technical advancements in alternative treatments potentially reducing demand for Phenazone.